Effects of Rosmarinic Acid and Doxorubicin on Ovarian Cancer Cells
Author Information
Author(s): Toprak Veysel, Özdemir İlhan, Öztürk Şamil, Yanar Orhan, Kizildemir Yusuf Ziya, Tuncer Mehmet Cudi
Primary Institution: Dicle University
Hypothesis
How do rosmarinic acid and doxorubicin affect FOXP3 gene expression in OVCAR3 cells?
Conclusion
Rosmarinic acid and doxorubicin together can inhibit ovarian cancer cell growth and affect important gene expressions related to cancer progression.
Supporting Evidence
- Rosmarinic acid and doxorubicin inhibited the proliferation of OVCAR3 cells.
- Caspase-3 expression increased significantly in treated cells, indicating apoptosis.
- FOXP3 expression was upregulated with rosmarinic acid but downregulated with doxorubicin.
- The combination treatment showed higher efficacy in reducing cell viability.
- Statistical significance was observed in multiple treatment comparisons.
Takeaway
This study shows that a natural compound called rosmarinic acid can help make cancer cells more sensitive to a common chemotherapy drug, doxorubicin.
Methodology
The study used MTT analysis for cell proliferation, RT-qPCR for gene expression, and a wound healing model for cell migration.
Limitations
The study design may benefit from additional experiments and markers to better illustrate the effects of the treatments.
Statistical Information
P-Value
p ≤ 0.0001
Statistical Significance
p ≤ 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website